Central Trust Company’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-18
Closed -$941 1675
2026
Q1
$941 Buy
+18
New +$1.08K ﹤0.01% 1429
2025
Q2
Sell
-50
Closed -$2.93K 1484
2025
Q1
$2.93K Sell
50
-528
-91% -$35.8K ﹤0.01% 1281
2024
Q4
$41.6K Sell
578
-401
-41% -$29.4K ﹤0.01% 836
2024
Q3
$78.3K Buy
979
+1
+0.1% +$75 ﹤0.01% 700
2024
Q2
$70.1K Sell
978
-10
-1% -$736 ﹤0.01% 712
2024
Q1
$69.5K Hold
988
﹤0.01% 750
2023
Q4
$76.2K Hold
988
﹤0.01% 723
2023
Q3
$67.3K Sell
988
-60
-6% -$4.74K ﹤0.01% 724
2023
Q2
$85.5K Sell
1,048
-40
-4% -$3.21K ﹤0.01% 695
2023
Q1
$80.7K Hold
1,088
﹤0.01% 705
2022
Q4
$90.2K Sell
1,088
-72
-6% -$5.72K ﹤0.01% 668
2022
Q3
$82K Hold
1,160
﹤0.01% 692
2022
Q2
$100K Hold
1,160
﹤0.01% 648
2022
Q1
$125K Hold
1,160
﹤0.01% 649
2021
Q4
$150K Buy
1,160
+928
+400% +$114K ﹤0.01% 622
2021
Q3
$28K Hold
232
﹤0.01% 860
2021
Q2
$26K Sell
232
-40
-15% -$4.21K ﹤0.01% 840
2021
Q1
$26K Sell
272
-28
-9% -$2.55K ﹤0.01% 793
2020
Q4
$24K Hold
300
﹤0.01% 778
2020
Q3
$19K Sell
300
-12
-4% -$781 ﹤0.01% 773
2020
Q2
$21K Sell
312
-88
-22% -$5.27K ﹤0.01% 740
2020
Q1
$19K Hold
400
﹤0.01% 766
2019
Q4
$22K Hold
400
﹤0.01% 819
2019
Q3
$20K Hold
400
﹤0.01% 796
2019
Q2
$21K Sell
400
-80
-17% -$4.03K ﹤0.01% 790
2019
Q1
$24K Sell
480
-1,348
-74% -$60.7K ﹤0.01% 744
2018
Q4
$66K Sell
1,828
-15,000
-89% -$627K ﹤0.01% 592
2018
Q3
$859K Sell
16,828
-260
-2% -$11.5K 0.05% 257
2018
Q2
$632K Hold
17,088
0.04% 300
2018
Q1
$645K Buy
+17,088
New +$604K 0.04% 300
2015
Q4
Sell
-352
Closed -$8K 1206
2015
Q3
$8K Hold
352
﹤0.01% 1023
2015
Q2
$9K Hold
352
﹤0.01% 1030
2015
Q1
$9K Hold
352
﹤0.01% 1005
2014
Q4
$8K Hold
352
﹤0.01% 1019
2014
Q3
$8K Hold
352
﹤0.01% 1017
2014
Q2
$8K Hold
352
﹤0.01% 1003
2014
Q1
$8K Buy
+352
New +$7.92K ﹤0.01% 992

Other funds holding TECH

Central Trust Company's TECH Position: Q2 2026 in Review

Central Trust Company sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 18 shares — an estimated $941 sold.

Central Trust Company first reported a position in TECH in Q1 2014 and held it in 37 quarters. The position peaked at $859K in Q3 2018. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Central Trust Company reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
  • Central Trust Company sold 18 Bio-Techne shares in Q2 2026, an estimated $941.
  • Central Trust Company first reported a position in Bio-Techne in Q1 2014 and held it in 37 quarters.
  • Central Trust Company's Bio-Techne position peaked at $859K in Q3 2018.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Central Trust Company's 13F filing for Q2 2026, filed 31 Jul 2026.